Risk of severe clinical events after sustained virological response following direct‐acting antiviral therapy in HIV and hepatitis C virus coinfected participants

Chalouni, Mathieu; Wittkop, Linda; Bani‐Sadr, Firouzé; Lacombe, Karine; Esterle, Laure; Gilbert, Camille; Miailhes, Patrick; Zucman, David; Antoine Valantin, Marc; Brégigeon‐Ronot, Sylvie; Morlat, Philippe; Billaud, Eric; Piroth, Lionel; Naqvi, Alissa; Sogni, Philippe; Salmon, Dominique; the ANRS CO13 HEPAVIH Cohort Study Group, for

doi:10.1111/hiv.13127

Public

Risk of severe clinical events after sustained virological response following direct‐acting antiviral therapy in HIV and hepatitis C virus coinfected participants

Published in HIV Medicine • Jul 1, 2021

Authors:

Mathieu Chalouni

Linda Wittkop

Firouzé Bani‐Sadr

Abstract

OBJECTIVES: Sustained virological response (SVR) decreases the risk of hepatitis C virus (HCV)-related events. Nevertheless, a substantial risk of events persists. We estimated incidences and identified factors associated with severe clinical events after SVR following treatment with a direct-acting...

Subject

Medicine

Internal medicine

Incidence (geometry)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!